Visible Ink Founder Judith Kelman was interviewed about the program that offers patients at Memorial Sloan-Kettering the opportunity to work one-on-one with an experienced mentor on a writing project of their choice.
Memorial Sloan-Kettering launched a transformative initiative to improve the quality of cancer care and the lives of cancer patients. Hartford HealthCare was selected as a pioneering member of the newly formed Memorial Sloan-Kettering Cancer Alliance.
Memorial Sloan-Kettering Physician-in-Chief José Baselga commented on the recommendation from a federal advisory panel to approve the first drug that would be used in early-stage breast cancer patients, prior to surgery.
Head and neck cancer surgeon Bhuvanesh Singh commented on a paper that found that the number of cases of thyroid cancer in the United States tripled from 1973 to 2009, largely due to more aggressive screening techniques and improved imaging.